Cabaletta Bio News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

18.11.24	Cabaletta Bio Reveals CABA-201's Positive Clinical Safety And Efficacy Data (RTTNews)
20.03.24	Cabaletta Bio Says FDA Grants Orphan Drug Designation To CABA-201 To Treat Systemic Sclerosis (RTTNews)
06.11.23	Cabaletta Bio Gets FDA's Nod For CABA-201 INDA For Generalized Myasthenia Gravis (RTTNews)
02.10.23	Cabaletta Bio: IND Application For CABA-201 Gets FDA Clearance To Treat Systemic Sclerosis (RTTNews)
21.06.23	Pre-market Movers: VCIG, DTI, PCT, KWE, AULT… (RTTNews)
19.01.23	12 Biotech Stocks Hit New Highs; Did You Make The Most Of It? (RTTNews)
26.04.22	CABA FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Friday Deadline in Securities Class Action - CABA (PR Newswire)
19.04.22	CABA INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important April 29 Deadline in Securities Class Action - CABA (PR Newswire)
04.04.22	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important April 29 Deadline in Securities Class Action - CABA (PR Newswire)
28.03.22	CABA LOSS ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA (PR Newswire)
23.03.22	CABA SHAREHOLDER ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securiti... (PR Newswire)
14.03.22	ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA (PR Newswire)
05.03.22	ROSEN, A TOP RANKED FIRM, Encourages Cabaletta Bio, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA (PR Newswire)
30.01.20	CABA Hits New High, IMMP On Watch, SBPH Drops CATALYST (RTTNews)
12.11.19	Today's Top 5 Gainers In Healthcare Sector (CABA, INMD, AQST…) (RTTNews)
04.11.19	Healthcare Stocks That Hit New Highs ( AMED, BRKR, RDNT,...) (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V